Dr. Pavletic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 Center Dr
Bethesda, MD 20892Phone+1 301-402-4899- Is this information wrong?
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1992 - 1995
University of Zagreb Faculty of MedicineClass of 1979
Certifications & Licensure
NE State Medical License 1993 - 2024
Clinical Trials
- Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease Start of enrollment: 2004 Oct 26
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System Start of enrollment: 2007 Oct 30
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders Start of enrollment: 2009 Aug 25
- Join now to see all
Publications & Presentations
PubMed
- Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease.Rosenstein, R., Rose, J., Brooks, S., Tsai, W., Gadina, M., Nagao, K., Pavletic, S., Cowen, E.> ;JID Innovations. 2024 Mar 1
- The evolution of preclinical models for myelodysplastic neoplasms.Alain Mina, Steven Pavletic, Peter D Aplan> ;Leukemia. 2024 Apr 1
- Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.Bracken, S., Suthers, A., DiCioccio, R., Su, H., Anand, S., Poe, J., Jia, W., Visentin, J., Basher, F., Jordan, C., McManigle, W., Li, Z., Hakim, F., Pavletic, S., Bhu...> ;Blood Advances. 2024 Feb 13
- Join now to see all
Journal Articles
- Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected PatientsLauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature
- The eGVHD App Has the Potential to Improve the Accuracy of Graft Versus Host Disease Assessment: A Multicenter Randomized Controlled TrialAnnie Im, Steven Z Pavletic, Haematologica
Abstracts/Posters
- Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic GvhdSteven Z. Pavletic, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
- Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic MalignancySteven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
GVHD Alliance to Honor Steven Pavletic with the Inaugural Lukas D. Wartman GVHD Achievement AwardFebruary 16th, 2023- The Future of Chronic Graft-Versus-Host DiseaseFebruary 1st, 2021
New Drugs Aim to Disarm the Immune System’s ‘Atomic Bomb’ CellsMarch 5th, 2020- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
NIH Clinical CenterBethesda, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
